Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Nitric oxide production and endothelium-dependent vasorelaxation ameliorated by N1-methylnicotinamide in human blood vessels.

Domagala TB, Szeffler A, Dobrucki LW, Dropinski J, Polanski S, Leszczynska-Wiloch M, Kotula-Horowitz K, Wojciechowski J, Wojnowski L, Szczeklik A, Kalinowski L.

Hypertension. 2012 Apr;59(4):825-32. doi: 10.1161/HYPERTENSIONAHA.111.183210. Epub 2012 Feb 21.

2.

Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelial nitric oxide synthase in healthy normolipidemic older adults.

Walker AE, Kaplon RE, Lucking SM, Russell-Nowlan MJ, Eckel RH, Seals DR.

Hypertension. 2012 Dec;60(6):1517-23. doi: 10.1161/HYPERTENSIONAHA.112.203661. Epub 2012 Oct 29.

3.

Sex differences in salt sensitivity to nitric oxide dependent vasodilation in healthy young adults.

Eisenach JH, Gullixson LR, Kost SL, Joyner MJ, Turner ST, Nicholson WT.

J Appl Physiol (1985). 2012 Mar;112(6):1049-53. doi: 10.1152/japplphysiol.01197.2011. Epub 2011 Dec 22.

4.

1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats.

Bartuś M, Łomnicka M, Kostogrys RB, Kaźmierczak P, Watała C, Słominska EM, Smoleński RT, Pisulewski PM, Adamus J, Gebicki J, Chlopicki S.

Pharmacol Rep. 2008 Jan-Feb;60(1):127-38.

5.

Dietary phosphorus acutely impairs endothelial function.

Shuto E, Taketani Y, Tanaka R, Harada N, Isshiki M, Sato M, Nashiki K, Amo K, Yamamoto H, Higashi Y, Nakaya Y, Takeda E.

J Am Soc Nephrol. 2009 Jul;20(7):1504-12. doi: 10.1681/ASN.2008101106. Epub 2009 Apr 30.

6.

The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.

Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA.

Circulation. 1993 Dec;88(6):2541-7.

PMID:
8252665
7.

Effects of high-density lipoprotein on endothelium-dependent vasorelaxation.

McAllister RM, Morris DM, Weimer CM, Laughlin MH.

Appl Physiol Nutr Metab. 2010 Jun;35(3):319-27. doi: 10.1139/H10-026.

PMID:
20555376
8.

Cicletanine stimulates nitric oxide release and scavenges superoxide in endothelial cells.

Kalinowski L, Dobrucki IT, Malinski T.

J Cardiovasc Pharmacol. 2001 Jun;37(6):713-24.

PMID:
11392468
9.

Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.

Münzel T, Li H, Mollnau H, Hink U, Matheis E, Hartmann M, Oelze M, Skatchkov M, Warnholtz A, Duncker L, Meinertz T, Förstermann U.

Circ Res. 2000 Jan 7;86(1):E7-E12.

10.

Nitric oxide synthase-dependent vasodilation of human subcutaneous arterioles correlates with noninvasive measurements of endothelial function.

Dharmashankar K, Welsh A, Wang J, Kizhakekuttu TJ, Ying R, Gutterman DD, Widlansky ME.

Am J Hypertens. 2012 May;25(5):528-34. doi: 10.1038/ajh.2012.8. Epub 2012 Feb 16.

11.

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

Spieker LE, Sudano I, Hürlimann D, Lerch PG, Lang MG, Binggeli C, Corti R, Ruschitzka F, Lüscher TF, Noll G.

Circulation. 2002 Mar 26;105(12):1399-402.

12.
13.

Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.

Gates PE, Boucher ML, Silver AE, Monahan KD, Seals DR.

J Appl Physiol (1985). 2007 Jan;102(1):63-71. Epub 2006 Aug 31.

14.

Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.

Cheang WS, Wong WT, Tian XY, Yang Q, Lee HK, He GW, Yao X, Huang Y.

Cardiovasc Res. 2011 Nov 1;92(2):267-75. doi: 10.1093/cvr/cvr233. Epub 2011 Aug 29.

PMID:
21875904
15.

Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation.

Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC.

Circulation. 2001 Oct 16;104(16):1905-10.

16.

Anti-diabetic effects of 1-methylnicotinamide (MNA) in streptozocin-induced diabetes in rats.

Watała C, Kaźmierczak P, Dobaczewski M, Przygodzki T, Bartuś M, Łomnicka M, Słomińska EM, Durackova Z, Chłopicki S.

Pharmacol Rep. 2009 Jan-Feb;61(1):86-98.

17.

Relationship between changes in brachial artery flow-mediated dilation and basal release of nitric oxide in subjects with Type 2 diabetes.

Green DJ, Maiorana AJ, Tschakovsky ME, Pyke KE, Weisbrod CJ, O'Driscoll G.

Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1193-9. Epub 2006 Mar 24.

18.

Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.

Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T, Cunnington C, Tousoulis D, Pillai R, Ratnatunga C, Stefanadis C, Channon KM.

Eur Heart J. 2009 May;30(9):1142-50. doi: 10.1093/eurheartj/ehp061. Epub 2009 Mar 18.

PMID:
19297385
19.

Endothelium-dependent NO-mediated vasodilation in humans is attenuated by peripheral alpa1-adrenoceptor activation.

Kamper AM, de Craen AJ, Westendorp RG, Blauw GJ.

Vasc Health Risk Manag. 2005;1(3):251-6.

20.

20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling.

Cheng J, Ou JS, Singh H, Falck JR, Narsimhaswamy D, Pritchard KA Jr, Schwartzman ML.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H1018-26. Epub 2007 Dec 21.

Supplemental Content

Support Center